Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Epithelial Pleural Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06566079
What this trial is testing

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Who this might be right for
Malignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor
InSilico Medicine Hong Kong Limited 160
Large-scale testing (Phase 3)Ended earlyNCT01604005
What this trial is testing

PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Brynn Chappell 375
Not applicableWithdrawnNCT01325753
What this trial is testing

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

Who this might be right for
Advanced Malignant MesotheliomaExtensive Stage Small Cell Lung CancerLung Metastases+4 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT00107432
What this trial is testing

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.

Who this might be right for
Epithelial MesotheliomaRecurrent Malignant MesotheliomaSarcomatous Mesothelioma+5 more
National Cancer Institute (NCI) 44
Early research (Phase 1)Ended earlyNCT01445392
What this trial is testing

SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 24
Early research (Phase 1)Ended earlyNCT02707666
What this trial is testing

A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
University of Chicago 7
Testing effectiveness (Phase 2)Study completedNCT03213301
What this trial is testing

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.

Who this might be right for
Malignant Pleural Mesothelioma, Advanced
Swiss Cancer Institute 42
Testing effectiveness (Phase 2)Study completedNCT00407459
What this trial is testing

Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Armando Santoro, MD 77
Testing effectiveness (Phase 2)Ended earlyNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 14
Testing effectiveness (Phase 2)Ended earlyNCT00895648
What this trial is testing

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma

Who this might be right for
MesotheliomaPleural Mesothelioma
University Health Network, Toronto 6
Not applicableStudy completedNCT06581549
What this trial is testing

Immune Microenvironment and Gene Expression Profiling in Mesothelioma

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma; Lung
Istituto Oncologico Veneto IRCCS 125
Not applicableNot Yet RecruitingNCT07550049
What this trial is testing

Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology

Who this might be right for
Small Cell Lung CancerHead and Neck CancerMalignant Pleural Mesothelioma
University of Kansas Medical Center 110
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Not applicableUnknownNCT03558932
What this trial is testing

IP3R Modulation by Cancer Genes in Mesothelioma

Who this might be right for
Malignant Mesothelioma
KU Leuven 20
Early research (Phase 1)WithdrawnNCT05375825
What this trial is testing

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Who this might be right for
Malignant Pleural Mesotheliomas (Mpm)Malignant Pleural Effusions (Mpe)Epithelial Tumors, Malignant+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03177668
What this trial is testing

Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Kissei Pharmaceutical Co., Ltd. 40
Not applicableWithdrawnNCT04214015
What this trial is testing

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

Who this might be right for
MesotheliomaMesothelioma MalignantMesothelioma; Lung+4 more
ProgenaBiome
Not applicableWithdrawnNCT00733252
What this trial is testing

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+2 more
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT02369198
What this trial is testing

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC

Who this might be right for
Malignant Pleural MesotheliomaNon-Small Cell Lung Cancer
Asbestos Diseases Research Foundation 27
Testing effectiveness (Phase 2)Study completedNCT01112293
What this trial is testing

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Who this might be right for
Pleural Malignant Mesothelioma
Abramson Cancer Center at Penn Medicine 14
Next Page